Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I data support safety of TissueGene-C in osteoarthritis

Oct. 5, 2010

Intranasal XF-73 well tolerated in phase I study

Oct. 5, 2010

Preclinical and clinical data reported on neoglycoside ACHN-490

Oct. 5, 2010

PH-797804 improves lung function in patients with COPD

Oct. 5, 2010

MedImmune reports clinical data on asthma candidates MEDI-563 and MEDI-528

Oct. 5, 2010

Phase II trial of IMA-901 shows benefit of cyclophosphamide pretreatment

Oct. 4, 2010

NNC-126-0083 is well tolerated in adults and children with growth hormone deficiency

Oct. 4, 2010

Phase I investigation of CombiHIVvac HIV vaccine begins

Oct. 4, 2010

EP-017796 is active against drug-resistant bacteria

Oct. 4, 2010

Cationic peptide NP-339 is active against Candida species

Oct. 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...